argenx SE (ARGX)
366.02
-10.58
(-2.81%)
USD |
NASDAQ |
May 17, 16:00
366.02
0.00 (0.00%)
After-Hours: 20:00
argenx Gross Profit (TTM): 1.265B for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.265B |
| December 31, 2023 | 1.108B |
| September 30, 2023 | 902.50M |
| June 30, 2023 | 736.42M |
| March 31, 2023 | 560.08M |
| Date | Value |
|---|---|
| December 31, 2022 | 381.32M |
| September 30, 2022 | 245.96M |
| June 30, 2022 | 119.10M |
| March 31, 2022 | 361.16M |
| December 31, 2021 | 497.28M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
119.10M
Minimum
Jun 2022
1.265B
Maximum
Mar 2024
617.78M
Average
528.68M
Median
Gross Profit (TTM) Benchmarks
| Koninklijke Philips NV | 8.151B |
| Biodexa Pharmaceuticals Plc | -4.597M |
| NuCana PLC | -- |
| TC BioPharm (Holdings) PLC | -- |
| uniQure NV | -1.416M |